
|Articles|November 10, 2015
Measuring Response to Treatment in Multiple Myeloma
Author(s)C. Ola Landgren
C. Ola Landgren discusses ways to measure response to treatment in multiple myeloma.
Advertisement
C. Ola Landgren, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses ways to measure response to treatment in multiple myeloma. Landgren addressed this topic in a talk last week at the 33rd Annual Chemotherapy Foundation Symposium, a meeting of over 1,000 physicians and other oncology professionals in New York City.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
New Combination Treatment Approach Studied in Pancreatic Cancer
5




